drugset / Trial / NCT05160831

Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis

NCT05160831

Unknown 50 enrolled Southwest Hospital, China
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the effectiveness and safety of human umbilical cord mesenchymal stem cell injection in the articular cavity to treat moderate to severe knee osteoarthritis (OA), and whether it can achieve articular cartilage regeneration, reduction of joint pain, and restoration of joint function.

Timeline

Start
2022-01-20
Primary completion
2023-01-20
Completion
2024-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject human umbilical cord mesenchymal stem cells Cell therapy Other

Indications